company background image
0ACT logo

AlzChem Group LSE:0ACT Stock Report

Last Price

€44.80

Market Cap

€456.9m

7D

4.4%

1Y

135.4%

Updated

25 Apr, 2024

Data

Company Financials +

0ACT Stock Overview

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally.

0ACT fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance6/6
Financial Health6/6
Dividends3/6

AlzChem Group AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AlzChem Group
Historical stock prices
Current Share Price€44.80
52 Week High€46.75
52 Week Low€18.50
Beta1.1
1 Month Change34.78%
3 Month Change79.19%
1 Year Change135.44%
3 Year Changen/a
5 Year Changen/a
Change since IPO118.20%

Recent News & Updates

Recent updates

Shareholder Returns

0ACTGB ChemicalsGB Market
7D4.4%-2.9%2.2%
1Y135.4%-37.5%0.9%

Return vs Industry: 0ACT exceeded the UK Chemicals industry which returned -37% over the past year.

Return vs Market: 0ACT exceeded the UK Market which returned 0.6% over the past year.

Price Volatility

Is 0ACT's price volatile compared to industry and market?
0ACT volatility
0ACT Average Weekly Movementn/a
Chemicals Industry Average Movement6.9%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.7%

Stable Share Price: 0ACT's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine 0ACT's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19081,607Andreas Niedermaierwww.alzchem.com

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand.

AlzChem Group AG Fundamentals Summary

How do AlzChem Group's earnings and revenue compare to its market cap?
0ACT fundamental statistics
Market cap€456.92m
Earnings (TTM)€34.62m
Revenue (TTM)€545.79m

13.2x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0ACT income statement (TTM)
Revenue€545.79m
Cost of Revenue€241.72m
Gross Profit€304.07m
Other Expenses€269.45m
Earnings€34.62m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 29, 2024

Earnings per share (EPS)3.40
Gross Margin55.71%
Net Profit Margin6.34%
Debt/Equity Ratio35.2%

How did 0ACT perform over the long term?

See historical performance and comparison

Dividends

2.7%

Current Dividend Yield

35%

Payout Ratio

Does 0ACT pay a reliable dividends?

See 0ACT dividend history and benchmarks
When do you need to buy 0ACT by to receive an upcoming dividend?
AlzChem Group dividend dates
Ex Dividend DateMay 08 2024
Dividend Pay DateMay 10 2024
Days until Ex dividend12 days
Days until Dividend pay date14 days

Does 0ACT pay a reliable dividends?

See 0ACT dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.